LGND (STOCKS)
Ligand Pharmaceuticals Inc.
$298.500000
+3.510000 (+1.19%)
Prev close: $294.990000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Todd Christopher Davis
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5,946.79M
- Employees
- 68
- P/E (TTM)
- 31.54
- P/B (TTM)
- 6.07
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$2.37 | $1.86 | +0.5088 | +27.34% |
|
Mar 2026 (Q1)
|
$1.63 | $1.85 | -0.2220 | -11.99% |
|
Dec 2025 (Q4)
|
$2.02 | $1.59 | +0.4274 | +26.84% |
|
Sep 2025 (Q3)
|
$3.09 | $1.96 | +1.1258 | +57.32% |